Filing Flows › Insulet (PODD) › Capital expenditures
Insulet (PODD) capital expenditures by quarter
Insulet's capital expenditures were $57.1M in Q3 2026 (third quarter 2026), +76% from Q2 2026. Over the last 7 quarters it ranged from $12.3M (Q1 2025) to $135M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $57.1M | +76% | +123% |
| Q2 2026 | $32.5M | +34% | +75% |
| Q1 2026 | $24.3M | -82% | +98% |
| Q4 2025 | $135M | +428% | — |
| Q3 2025 | $25.6M | +38% | — |
| Q2 2025 | $18.6M | +51% | — |
| Q1 2025 | $12.3M | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's capital expenditures?
Insulet's capital expenditures were $57.1M in Q3 2026 (third quarter 2026), +76% from Q2 2026.
How has Insulet's capital expenditures changed?
Over the last 7 quarters it ranged from $12.3M (Q1 2025) to $135M (Q4 2025).